Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Officer

BETHESDA, Md., April 08, 2024 -- Gain Therapeutics, Inc. , a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule...

Related Keywords

Switzerland ,Swiss ,Elio Ambrosio ,Nic Johnson ,Matthias Alder ,Gruntal Co ,Exchange Commission ,European Union Horizon ,Swiss Innovation Agency ,Gain Therapeutics Inc ,Fordham University ,Michaelj Fox Foundation For Parkinson Research ,Lazard ,Nasdaq ,Exchange Commission On ,Merck Co ,Linkedin ,Company Annual Report On Form ,Silverstein Foundation For Parkinson ,Gene Mack ,Gain Therapeutics ,Equity Incentive Plan ,Nasdaq Listing Rule ,Initial Vesting Date ,Silverstein Foundation ,Swiss Innovation ,Site Directed Enzyme Enhancement Therapy ,Private Securities Litigation Reform Act ,Annual Report ,